PetMed Express, Inc. (PETS) Stock Forecast
PETS analyst forecast
as of October 18, 2026- Analyst consensus
- Strong sell 1.00 / 5 from 1 analysts
- Price target
- $1.40 average of analyst targets
- Upside to target
- +18.6% from the latest close
- Next earnings
- —
- 52-week range
- $1.18 – $3.90
PETS analyst ratings
1 analystsNumber of analysts at each rating.
PETS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PETS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.11 | −$0.11 | −$0.11 | −$0.41 | +73.2% | 1 |
| Next quarter (Dec '26) | −$0.16 | −$0.16 | −$0.16 | −$0.50 | +68.0% | 1 |
| Current fiscal year (FY2027) | −$0.50 | −$0.50 | −$0.50 | −$2.74 | +81.8% | 1 |
| Next fiscal year (FY2028) | −$0.35 | −$0.35 | −$0.35 | −$0.50 | +30.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PETS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | — | — |
| Next quarter (Dec '26) | $0 | $0 | $0 | — | — |
| Current fiscal year (FY2027) | $149.2M | $149.2M | $149.2M | −16.7% | 1 |
| Next fiscal year (FY2028) | $152.5M | $152.5M | $152.5M | +2.2% | 1 |
PETS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PETS revenue: reported and forecast
PETS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.06 | −$0.06 | −$0.06 | −$0.06 | −$0.11 | +83.3% | 0 up · 1 down |
| Next quarter (Dec '26) | −$0.11 | −$0.11 | −$0.11 | −$0.11 | −$0.16 | +45.5% | 0 up · 1 down |
| Current fiscal year (FY2027) | $0.07 | $0.07 | $0.07 | $0.07 | −$0.50 | −814.3% | 0 up · 1 down |
| Next fiscal year (FY2028) | $0.09 | $0.09 | $0.09 | $0.09 | −$0.35 | −488.9% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PETS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PETS beat in 2 of 12.
What analysts expect from PETS
1 analysts cover PetMed Express; their consensus rating is strong sell (1.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $1.40, 18.6% above the latest close of $1.18. Analysts expect earnings of −$0.50 per share for FY2027, +81.8% from a year earlier. For FY2028 the average estimate is −$0.35 per share on revenue of $152.5 million. PetMed Express beat the EPS estimate in 2 of the last 12 quarters.
Related: PETS income statement, PETS key metrics, PETS chart. See the PETS stock overview for the latest quote and news.
PETS forecast FAQ
What is PetMed Express's price target?
The average analyst price target for PetMed Express is $1.40, 18.6% above the latest close of $1.18.
Is PetMed Express a buy, hold or sell?
Of 1 analysts covering PetMed Express, 0 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 1 a strong sell, a consensus of strong sell. Ratings are opinions, not a recommendation from Quotelinks.
What is PetMed Express's EPS forecast?
Analysts forecast −$0.50 per share for FY2027 (range −$0.50 to −$0.50); for FY2028 the estimate is −$0.35.
What is PetMed Express's revenue forecast?
The average revenue estimate for FY2027 is $149.2 million, growth of −16.7%; for FY2028 it is $152.5 million.
Does PetMed Express usually beat earnings estimates?
PetMed Express reported EPS at or above the analyst estimate in 2 of the last 12 quarters.